Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Compass Therapeutics Inc shares valued at $21,100 were purchased by Schuetz Thomas J. on May 27 ’25. At $2.11 per share, Schuetz Thomas J. acquired 10,000 shares. The insider’s holdings grew to 6,480,825 shares worth approximately $14.06 million following the completion of this transaction.
Also, GORDON CARL L sold 3,571,428 shares, netting a total of over 5,678,571 in proceeds. Following the sale of shares at $1.59 each, the insider now holds 0 shares.
Before that, ORBIMED ADVISORS LLC had sold 3,571,428 shares from its account. In a trade valued at $5,678,571, the Director traded Compass Therapeutics Inc shares for $1.59 each. Upon closing the transaction, the insider’s holdings decreased to 3,571,428 shares, worth approximately $0.0.
As published in a research note from Leerink Partners on April 02, 2025, Compass Therapeutics Inc [CMPX] has been rated up from a Market perform to an Outperform and the price target has been revised to $6. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in late February. As of February 19, 2025, Piper Sandler has initiated its “an Overweight” rating for CMPX. Earlier on December 23, 2024, D. Boral Capital initiated its rating. Their recommendation was “a Buy” for CMPX stock.
Analyzing CMPX Stock Performance
During the last five days, there has been a surge of approximately 3.33%. Over the course of the year, Compass Therapeutics Inc shares have jumped approximately 49.66%. Shares of the company reached a 52-week high of $4.08 on 02/11/25 and a 52-week low of $1.33 on 04/01/25.
Support And Resistance Levels for Compass Therapeutics Inc (CMPX)
According to the 24-hour chart, there is a support level at 2.13, which, if violated, would cause prices to drop to 2.09. In the upper region, resistance lies at 2.24. The next price resistance is at 2.30. RSI (Relative Strength Index) is 61.25 on the 14-day chart, showing neutral technical sentiment.
